Heterogeneity of response and survival in diffuse histiocytic lymphoma after BACOP therapy (bleomycin, doxorubicin, cyclophosphamide, vincristine, prednisone). (Q45051134)
Jump to navigation
Jump to search
scientific article published in April 1985
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Heterogeneity of response and survival in diffuse histiocytic lymphoma after BACOP therapy (bleomycin, doxorubicin, cyclophosphamide, vincristine, prednisone). |
scientific article published in April 1985 |
Statements
1 reference
Heterogeneity of response and survival in diffuse histiocytic lymphoma after BACOP therapy (bleomycin, doxorubicin, cyclophosphamide, vincristine, prednisone). (English)
1 reference
Levine AM
1 reference
Goldstein M
1 reference
Meyer PR
1 reference
Forman SJ
1 reference
Parker JW
1 reference
Paganini-Hill A
1 reference
Lukes RJ
1 reference
Feinstein DI
1 reference
1 April 1985
1 reference
1 reference
3
1 reference
2
1 reference
87-98
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference